- by sedlv
- April 27, 2023
Biomica Announces Closing of $20 Million Financing Round led by Shanghai Healthcare Capital
(April 27, 2023) | By Biomica Ltd.
REHOVOT, Israel, April 27, 2023 /PRNewswire/ — Biomica Ltd., a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), today announced that it has closed a financing round of $20 million. The round was led by a $10 million investment from Shanghai Healthcare Capital (SHC), a leading Chinese private equity fund based in Shanghai, focused on biotech and healthcare investments globally. Following the investment, SHC holds 20% of the share capital in Biomica on a fully-diluted basis. Evogene also invested $10 million in Biomica in the current financing round.